戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  patients (4 with meniscus pathology, 2 with vascular insufficiency).
2 g aetiology of ischaemic damage arising from vascular insufficiency.
3 bition of healing, most likely from regional vascular insufficiency.
4 irreversible complication of lower extremity vascular insufficiency.
5 As prevents placental growth restriction and vascular insufficiency.
6 ular responses in a mouse hind limb model of vascular insufficiency.
7 uding symptoms and signs of inflammation and vascular insufficiency, acute-phase reactants (APRs), an
8 , and the reminder perished due to placental vascular insufficiency and compromised vessel integrity.
9                                              Vascular insufficiency and retinal ischemia precede many
10 Localized GCA symptoms are the end-result of vascular insufficiency and tissue ischemia.
11 mains in question, the presence of lymphatic vascular insufficiency can be ascertained through imagin
12                              Upper extremity vascular insufficiency dominated the clinical presentati
13 is a disease of micronutrient deficiency and vascular insufficiency, due to detectable structural cha
14                                              Vascular insufficiency has been reported to be a cause o
15                                              Vascular insufficiency in PAD occurs despite higher circ
16               In a rabbit hind limb model of vascular insufficiency, intramuscular activation of Akt1
17 G and non-glaucoma controls, suggesting that vascular insufficiency or dysregulation by themselves ma
18 rial occlusion or more subtle but protracted vascular insufficiency, respectively, are leading causes
19 from the management strategies for lymphatic vascular insufficiency states.
20       Adverse events consistent with ongoing vascular insufficiency such as limb necrosis or gangrene
21 S1pr1 loss-of-function exacerbated lymphatic vascular insufficiency, tail swelling, and increased CD4
22 ature in order to circumvent or mitigate the vascular insufficiency that leads to edema and tissue de
23 w experimental strategy for the treatment of vascular insufficiency, uses the administration of media